Connacht Asset Management LP Cyma Bay Therapeutics, Inc. Transaction History
Connacht Asset Management LP
- $16.3 Million
- Q3 2023
A detailed history of Connacht Asset Management LP transactions in Cyma Bay Therapeutics, Inc. stock. As of the latest transaction made, Connacht Asset Management LP holds 11,986 shares of CBAY stock, worth $0. This represents 1.09% of its overall portfolio holdings.
Number of Shares
11,986
Previous 34,535
65.29%
Holding current value
$0
Previous $378,000
52.91%
% of portfolio
1.09%
Previous 0.53%
Shares
3 transactions
Others Institutions Holding CBAY
# of Institutions
11Shares Held
1.88MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iii, LLC Larkspur, CA1.64MShares$015.17% of portfolio
-
Abingworth LLP London, X0131KShares$00.27% of portfolio
-
Golden State Equity Partners South Coast Metro, CA54.3KShares$00.32% of portfolio
-
Ctc Capital Management, LLC10.7KShares$00.2% of portfolio
-
Pictet Asset Management Sa Geneva 73, V810.6KShares$00.0% of portfolio
About CymaBay Therapeutics, Inc.
- Ticker CBAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,677,904
- Description
- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...